Session 2

Moderator(s)

• 

  Shailja Shah, MD, MPH

  Professor of Medicine
  Jennifer Moreno Department of Veterans Affairs Medical Center
  San Diego, CA

Speaker(s)

• 

  Brooks Cash, MD, FACG (he/him/his)

  Professor of Medicine; Director of the Functional Bowel Center
  Baylor University Medical Center/ Baylor Scott and White Dallas
  Dallas, TX
• 

  Brian Lacy, MD, PhD, FACG (he/him/his)

  Professor of Medicine
  Mayo Clinic
  Jacksonville, FL
• 

  Joseph Lim, MD, FACG

  Professor of Medicine; Director, Clinical Hepatology
  Yale University School of Medicine
  New Haven, CT
• 

  Christopher Vélez, MD (he/him/his)

  Associate Program Director, Advanced Fellowship in Functional and Gastrointestinal Motility Disorders
  Massachusetts General Hospital, Mass General Brigham, Harvard Medical School
  Boston, MA

Presentations:

• 10:00 AM - 10:20 AM PDT

  Friend vs Foe: Cannabis and Cannabinoids as Instigators and Ameliorators in Gastrointestinal Diseases
  

  Speaker: Christopher D. Vélez, MD (he/him/his) – Massachusetts General Hospital, Mass General Brigham, Harvard Medical School
• 10:20 AM - 10:40 AM PDT

  What's in a Name? Pharmacologic Therapies for MASLD in 2025: When to Start, What to Start, and How to Monitor?
  

  Speaker: Joseph K. Lim, MD, FACG – Yale University School of Medicine
• 10:40 AM - 11:00 AM PDT

  Keep on Running: Pharmacologic Therapies for Chronic Diarrhea in Patients With Native vs Postsurgical Anatomy
  

  Speaker: Brooks D. Cash, MD, FACG (he/him/his) – Baylor University Medical Center/ Baylor Scott and White Dallas
• 11:00 AM - 11:20 AM PDT

  It's Not Easy Being Queasy: Pharmacologic Therapies for Chronic Nausea
  

  Speaker: Brian E. Lacy, MD, PhD, FACG (he/him/his) – Mayo Clinic
• 11:20 AM - 11:45 AM PDT

  Q & A 
  

  Moderator: Shailja C. Shah, MD, MPH – Jennifer Moreno Department of Veterans Affairs Medical Center